Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

Trial Identifier: D0816L00006
Sponsor:AstraZeneca
NCTID:NCT03063710

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
Japan, Tokyo Chuo-ku, Tokyo, Japan
Japan, Hyogo Akashi-shi, Hyogo, Japan